Table 2.
Clinical presentation of the patients
| N (%; n = 17) | |
|---|---|
| Affected side | |
| Left | 11 (64.7) |
| Right | 6 (35.3) |
| Localization | |
| Upper outer | 8 (47.1) |
| Upper inner | 1 (5.9) |
| Lower outer | 0 (0) |
| Lower inner | 4 (23.5) |
| Retroareolar space | 4 (23.5) |
| Axillary LAP | |
| Negative | 8 (47.1) |
| Positive | 9 (52.9) |
| Additional disease | |
| Negative | 14 (82.4) |
| Positive | 3 (17.6) |
| Initial complaint | |
| Pain | 2 (11.8) |
| Mass | 4 (23.5) |
| Pain + abscess | 3 (17.6) |
| Pain + mass | 4 (23.5) |
| Mass + abscess | 1 (5.9) |
| Pain + mass + abscess | 3(17.6) |
| Complication | |
| No complication | 14 (82.4) |
| Erythema | 2 (11.8) |
| Fistula | 1 (5.9) |
| Imaging | |
| USG | 8 (47.1) |
| USG + MG | 5 (29.4) |
| USG + MG + MRI | 4 (23.5) |
| BIRADS | |
| 1 | 0 (0) |
| 2 | 0 (0) |
| 3 | 9 (52.9) |
| 4 | 7 (41.2) |
| 5 | 1 (5.9) |
| Biopsy | |
| Tru-Cut | 13 (76.5) |
| Drainage + incisional biopsy | 4 (23.5) |
USG, ultrasonography; MG, mammography; MRI, magnetic resonance imaging.